{"id":"https://openalex.org/W2089529554","doi":"https://doi.org/10.1097/00001721-199509000-00007","title":"Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia","display_name":"Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia","alternate_titles":[],"publication_year":1995,"publication_date":"1995-09-01","ids":{"openalex":"https://openalex.org/W2089529554","doi":"https://doi.org/10.1097/00001721-199509000-00007","mag":"2089529554","pmid":"https://pubmed.ncbi.nlm.nih.gov/7578896"},"language":"en","primary_location":{"id":"doi:10.1097/00001721-199509000-00007","doi":"https://doi.org/10.1097/00001721-199509000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001721-199509000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S118812467","display_name":"Blood Coagulation & Fibrinolysis","issn_l":"0957-5235","issn":["0957-5235","1473-5733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Coagulation &amp; Fibrinolysis","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2089529554"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059173192","display_name":"Giuseppe Avellone","orcid":"https://orcid.org/0000-0002-4539-6059","observed_orcids":["https://orcid.org/0000-0002-4539-6059"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Avellone","raw_affiliation_strings":["Institute of Clinical Medicine, University of Palermo, Italy","Institute of Clinical Medicine, Univ of Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Medicine, University of Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Institute of Clinical Medicine, Univ of Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005714507","display_name":"Vincenzo Di Garbo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"V. Di Garbo","raw_affiliation_strings":["G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108443824","display_name":"Rosamaria Cordova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R. Cordova","raw_affiliation_strings":["G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067997077","display_name":"Teodoro Piliego","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"T. Piliego","raw_affiliation_strings":["G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005848939","display_name":"Gilia Raneli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Raneli","raw_affiliation_strings":["G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. De Simone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R. De Simone","raw_affiliation_strings":["G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024841566","display_name":"GianDomenico Bompiani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. D. Bompiani","raw_affiliation_strings":["G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G. Avellone, V Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. D. Bompiani are with the Institute of Clinical Medicine, University of Palermo, Italy and T. Piliego is with the Medical Department Parke-Davis S.p.A, Lainate, Italy","institution_ids":["https://openalex.org/I900890020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I900890020"],"apc_list":null,"apc_paid":null,"fwci":1.8206,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.84867523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"6","issue":"6","first_page":"543","last_page":"548"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.5400000214576721,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.5400000214576721,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.45019999146461487,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":1.0},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9100000262260437},{"id":"https://openalex.org/keywords/fibrinolysis","display_name":"fibrinolysis","score":0.8140000104904175},{"id":"https://openalex.org/keywords/plasma-lipoproteins","display_name":"serum lipoproteins","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9739999771118164},{"id":"https://openalex.org/keywords/hdl2-c","display_name":"HDL2-C","score":0.7860000133514404},{"id":"https://openalex.org/keywords/hdl3-c","display_name":"HDL3-C","score":0.8619999885559082},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7170000076293945},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.6930000185966492},{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.8220000267028809},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor","display_name":"plasminogen activator inhibitor","score":0.9129999876022339},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.7459999918937683},{"id":"https://openalex.org/keywords/factor-vii","display_name":"factor VII","score":0.984000027179718},{"id":"https://openalex.org/keywords/reverse-cholesterol-transport","display_name":"reverse cholesterol transport","score":0.9120000004768372},{"id":"https://openalex.org/keywords/venous-occlusion","display_name":"venous occlusion","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2778670441","wikidata":"https://www.wikidata.org/wiki/Q384295","display_name":"Gemfibrozil","level":3,"score":0.8977580666542053},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.8486377000808716},{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.7365677356719971},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6138990521430969},{"id":"https://openalex.org/C2776104379","wikidata":"https://www.wikidata.org/wiki/Q21112670","display_name":"Lipoprotein(a)","level":4,"score":0.5515137910842896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5033857226371765},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47798460721969604},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.45642656087875366},{"id":"https://openalex.org/C2993401043","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Plasma lipoprotein","level":4,"score":0.4428812265396118},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.21587494015693665},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.2086467146873474}],"mesh":[{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005167","descriptor_name":"Factor VII","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005342","descriptor_name":"Fibrinolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010958","descriptor_name":"Plasminogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015248","descriptor_name":"Gemfibrozil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016632","descriptor_name":"Apolipoprotein A-I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001721-199509000-00007","doi":"https://doi.org/10.1097/00001721-199509000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001721-199509000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S118812467","display_name":"Blood Coagulation & Fibrinolysis","issn_l":"0957-5235","issn":["0957-5235","1473-5733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Coagulation &amp; Fibrinolysis","raw_type":"journal-article"},{"id":"pmid:7578896","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7578896","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1982746680","https://openalex.org/W2161873621","https://openalex.org/W1983618463","https://openalex.org/W2040376180","https://openalex.org/W1965527583","https://openalex.org/W2007213864","https://openalex.org/W2409991164","https://openalex.org/W2088055802","https://openalex.org/W2052739606","https://openalex.org/W161208641"],"abstract_inverted_index":{"A":[0],"randomized":[1],"double-blind":[2,60],"study":[3],"was":[4,40,128,149,156],"carried":[5],"out":[6],"with":[7,47],"gemfibrozil":[8,48,116,138],"(600":[9],"mg":[10],"b.i.d.)":[11],"vs":[12],"placebo":[13,53,161],"in":[14,58,136,144,160,214,228],"20":[15],"patients":[16],"(twelve":[17],"males":[18],"and":[19,66,70,76,83,87,103,105,111,125,152,169,178,182,191,197,235],"eight":[20],"females,":[21],"age":[22],"52":[23],"+/-":[24,29],"3":[25],"years,":[26],"BMI":[27],"24.2":[28],"0.4)":[30],"suffering":[31],"from":[32],"primary":[33],"hypertriglyceridemia":[34],"(Fredrickson's":[35],"type":[36],"IV).":[37],"Each":[38],"group":[39,96,139],"treated":[41],"for":[42],"a":[43,59,97,106,118,192,225],"12":[44,132],"week":[45],"period":[46],"(n":[49,54],"=":[50,55,173,186,201],"10)":[51,56],"or":[52],"patients)":[57],"fashion.":[61],"Total":[62],"cholesterol,":[63],"HDL-cholesterol":[64],"(HDL-C)":[65],"its":[67],"subfractions":[68],"(HDL2-C":[69],"HDL3-C),":[71],"blood":[72],"glucose,":[73],"Apolipoproteins":[74],"A1":[75],"B,":[77],"fibrinogen,":[78],"plasminogen,":[79],"factor":[80,122],"VII,":[81,123],"t-PA:Ag":[82,143,170,183,198],"PAI":[84,154],"activity":[85,155],"pre-":[86],"post-venous":[88],"occlusion":[89,148],"(VO)":[90],"were":[91,113,206],"determined.":[92],"In":[93],"the":[94,137,140,217,229],"gemfibrozil-treated":[95],"significant":[98,107,119],"decrease":[99],"of":[100,109,121,134,142,231],"total":[101],"cholesterol":[102,168,181,233],"triglycerides":[104,196],"increase":[108],"HDL-C":[110],"HDL2-C":[112,180],"found.":[114,207],"During":[115],"treatment":[117,135],"reduction":[120],"fibrinogen":[124],"plasminogen":[126],"levels":[127],"also":[129],"observed.":[130],"After":[131],"weeks":[133],"release":[141],"response":[145],"to":[146,216,223],"venous":[147],"significantly":[150,157],"higher":[151],"plasma":[153],"lower":[158],"than":[159],"group.":[162],"Moreover":[163],"positive":[164,226],"correlations":[165],"between":[166,179,195],"HDL":[167],"post-VO":[171,184,199],"(r":[172,185,200],"0.56,":[174],"P":[175,188,203],"<":[176,189,204],"0.01)":[177,190,205],"0.59,":[187],"negative":[193],"correlation":[194],"-0.65,":[202],"The":[208],"data":[209],"obtained":[210],"suggest":[211],"that":[212],"gemfibrozil,":[213],"addition":[215],"well":[218],"established":[219],"lipid-regulating":[220],"effect,":[221],"appears":[222],"have":[224],"role":[227],"regulation":[230],"reverse":[232],"transport":[234],"fibrinolytic":[236],"system.":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2089529554","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
